These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20877301)

  • 61. INSIG2 gene polymorphism is associated with higher blood pressure and triglyceride levels in Brazilian obese subjects.
    Nicoletti CF; Azevedo RG; Pinhel MAS; Delfino HBP; Nonino CB
    Nutr Hosp; 2019 Jul; 36(3):604-610. PubMed ID: 31144980
    [TBL] [Abstract][Full Text] [Related]  

  • 62. INSIG1 influences obesity-related hypertriglyceridemia in humans.
    Smith EM; Zhang Y; Baye TM; Gawrieh S; Cole R; Blangero J; Carless MA; Curran JE; Dyer TD; Abraham LJ; Moses EK; Kissebah AH; Martin LJ; Olivier M
    J Lipid Res; 2010 Apr; 51(4):701-8. PubMed ID: 19965593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome.
    Paredes RM; Quinones M; Marballi K; Gao X; Valdez C; Ahuja SS; Velligan D; Walss-Bass C
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1139-48. PubMed ID: 24565079
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Isolation, sequence characterization, and tissue transcription profiles of two novel buffalo genes: INSIG1 and INSIG2.
    Wu C; Liu L; Huo J; Li D; Yuan Y; Yuan F; Miao Y
    Trop Anim Health Prod; 2014 Jan; 46(1):33-41. PubMed ID: 23860946
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Association between polymorphism of rs10185316 in insulin-induced gene 2 and blood pressure among children and adolescents].
    Yang YD; Song JY; Liu FH; Shang XR; Wang HJ; Ma J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Oct; 51(10):939-942. PubMed ID: 29036998
    [No Abstract]   [Full Text] [Related]  

  • 66. INSIG2 variants, dietary patterns and metabolic risk in Samoa.
    Baylin A; Deka R; Tuitele J; Viali S; Weeks DE; McGarvey ST
    Eur J Clin Nutr; 2013 Jan; 67(1):101-7. PubMed ID: 22968099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.
    Kaur H; Jajodia A; Grover S; Baghel R; Gupta M; Jain S; Kukreti R
    PLoS One; 2014; 9(7):e102556. PubMed ID: 25025909
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of CNR1 and INSIG2 polymorphisms with antipsychotics-induced weight gain: a prospective nested case-control study.
    Jimeno N; Velasco-Gonzalez V; Fierro I; Duran M; Carvajal A
    Sci Rep; 2021 Jul; 11(1):15304. PubMed ID: 34315947
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration.
    Krapivner S; Chernogubova E; Ericsson M; Ahlbeck-Glader C; Hamsten A; van 't Hooft FM
    Diabetologia; 2007 Jan; 50(1):94-102. PubMed ID: 17106696
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Common INSIG2 polymorphisms are associated with age-related changes in body size and high-density lipoprotein cholesterol from young adulthood to middle age.
    Fornage M; Papanicolaou G; Lewis CE; Boerwinkle E; Siscovick DS
    Metabolism; 2010 Aug; 59(8):1084-91. PubMed ID: 20045156
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of INSIG2 polymorphism with overweight and LDL in children.
    Kaulfers AM; Deka R; Dolan L; Martin LJ
    PLoS One; 2015; 10(1):e0116340. PubMed ID: 25607990
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of an INSIG2 obesity allele with cardiovascular phenotypes is gender and age dependent.
    Skelding KA; Gerhard GS; Vlachos H; Selzer F; Kelsey SF; Chu X; Erdman R; Williams DO; Kip KE
    BMC Cardiovasc Disord; 2010 Sep; 10():46. PubMed ID: 20920244
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs).
    Ellingrod VL; Taylor SF; Brook RD; Evans SJ; Zöllner SK; Grove TB; Gardner KM; Bly MJ; Pop-Busui R; Dalack G
    Schizophr Res; 2011 Aug; 130(1-3):20-6. PubMed ID: 21504842
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metabolic effects of atypical antipsychotics: Molecular targets.
    Fonseca M; Carmo F; Martel F
    J Neuroendocrinol; 2023 Dec; 35(12):e13347. PubMed ID: 37866818
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences.
    Carli M; Kolachalam S; Longoni B; Pintaudi A; Baldini M; Aringhieri S; Fasciani I; Annibale P; Maggio R; Scarselli M
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33800403
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comment on "A common genetic variant is associated with adult and childhood obesity".
    Rosskopf D; Bornhorst A; Rimmbach C; Schwahn C; Kayser A; Krüger A; Tessmann G; Geissler I; Kroemer HK; Völzke H
    Science; 2007 Jan; 315(5809):187; author reply 187. PubMed ID: 17218510
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pathway-Driven Approaches of Interaction between Oxidative Balance and Genetic Polymorphism on Metabolic Syndrome.
    Lee HS; Park T
    Oxid Med Cell Longev; 2017; 2017():6873197. PubMed ID: 28191276
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolic syndrome in schizophrenia.
    Malhotra N; Grover S; Chakrabarti S; Kulhara P
    Indian J Psychol Med; 2013 Jul; 35(3):227-40. PubMed ID: 24249923
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics.
    Boiko AS; Mednova IA; Kornetova EG; Gerasimova VI; Kornetov AN; Loonen AJM; Bokhan NA; Ivanova SA
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34065135
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multi-omics analysis identifies rare variation in leptin/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes.
    Zhou W; Sun J; Huai C; Liu Y; Chen L; Yi Z; Lv Q; Song C; Zhu W; Liu C; Weng S; Wu H; Sun Y; Zhang R; Wu L; Li M; Zhu J; Zhang Y; Wei M; Guo Y; Huang S; Zhang N; Shen R; Zhang Y; Du H; Huang H; He L; Sun X; Shen L; Qin S
    Mol Psychiatry; 2022 Dec; 27(12):5195-5205. PubMed ID: 36065016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.